US Patent 11185537 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

Patent 11185537 was granted and assigned to Novartis on November, 2021 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

November 30, 2021

Patent Application Number

16504376

Date Filed

July 8, 2019

Patent Citations Received

Patent Primary Examiner

Patent abstract

The present disclosure provides a compound of Formula (I′):

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 11185537 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.